Computational Biology: Application and Advocacy
Barbara Bryant, Millennuim Pharmaceuticals and International Society for Computational Biology
This will be two talks in one time slot. I will present results from a Millennium Pharmaceuticals project, gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib. I will also talk about science policy advocacy with the help of the Federation of American Societies for Experimental Biology and the International Society for Computational Biology.
back to main page